<VariationArchive VariationID="2500925" VariationName="NM_024757.5(EHMT1):c.1051del (p.Asp351fs)" VariationType="Deletion" Accession="VCV002500925" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2023-05-07" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2523820" VariationID="2500925">
      <GeneList>
        <Gene Symbol="EHMT1" FullName="euchromatic histone lysine methyltransferase 1" GeneID="79813" HGNC_ID="HGNC:24650" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137619005" stop="137836127" display_start="137619005" display_stop="137836127" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140513443" stop="140730578" display_start="140513443" display_stop="140730578" Strand="+" />
          </Location>
          <OMIM>607001</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024757.5(EHMT1):c.1051del (p.Asp351fs)</Name>
      <CanonicalSPDI>NC_000009.12:137743969:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137743970" stop="137743970" display_start="137743970" display_stop="137743970" variantLength="1" positionVCF="137743969" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140638422" stop="140638422" display_start="140638422" display_stop="140638422" variantLength="1" positionVCF="140638421" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <OtherNameList>
        <Name>NM_001354612.2:c.958del</Name>
      </OtherNameList>
      <ProteinChange>D320fs</ProteinChange>
      <ProteinChange>D344fs</ProteinChange>
      <ProteinChange>D351fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.140638423del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.140638423del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.137743971del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.137743971del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011776.1" sequenceAccession="NG_011776" sequenceVersion="1" change="g.129980del">
            <Expression>NG_011776.1:g.129980del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001145527.2" sequenceAccession="NM_001145527" sequenceVersion="2" change="c.1051del">
            <Expression>NM_001145527.2:c.1051del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001138999.1" sequenceAccession="NP_001138999" sequenceVersion="1" change="p.Asp351fs">
            <Expression>NP_001138999.1:p.Asp351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354259.2" sequenceAccession="NM_001354259" sequenceVersion="2" change="c.958del">
            <Expression>NM_001354259.2:c.958del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341188.1" sequenceAccession="NP_001341188" sequenceVersion="1" change="p.Asp320fs">
            <Expression>NP_001341188.1:p.Asp320fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354263.2" sequenceAccession="NM_001354263" sequenceVersion="2" change="c.1030del">
            <Expression>NM_001354263.2:c.1030del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341192.1" sequenceAccession="NP_001341192" sequenceVersion="1" change="p.Asp344fs">
            <Expression>NP_001341192.1:p.Asp344fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354611.2" sequenceAccession="NM_001354611" sequenceVersion="2" change="c.1051del">
            <Expression>NM_001354611.2:c.1051del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341540.1" sequenceAccession="NP_001341540" sequenceVersion="1" change="p.Asp351fs">
            <Expression>NP_001341540.1:p.Asp351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354612.2" sequenceAccession="NM_001354612" sequenceVersion="2" change="c.958del">
            <Expression>NM_001354612.2:c.958del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341541.1" sequenceAccession="NP_001341541" sequenceVersion="1" change="p.Asp320fs">
            <Expression>NP_001341541.1:p.Asp320fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024757.5" sequenceAccession="NM_024757" sequenceVersion="5" change="c.1051del" MANESelect="true">
            <Expression>NM_024757.5:c.1051del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079033.4" sequenceAccession="NP_079033" sequenceVersion="4" change="p.Asp351fs">
            <Expression>NP_079033.4:p.Asp351fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024757.5(EHMT1):c.1051del (p.Asp351fs) AND Kleefstra syndrome 1" Accession="RCV003226110" Version="4">
        <ClassifiedConditionList TraitSetID="948">
          <ClassifiedCondition DB="MedGen" ID="C0795833">Kleefstra syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024757.5(EHMT1):c.1051del (p.Asp351fs) AND Kleefstra syndrome" Accession="RCV004017975" Version="2">
        <ClassifiedConditionList TraitSetID="52681">
          <ClassifiedCondition DB="MedGen" ID="C4551771">Kleefstra syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-10-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-02" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-05-07" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="52681" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="43204" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome</ElementValue>
                <XRef ID="MONDO:0012455" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS610253" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8672" />
                <XRef ID="8672" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C4551771" DB="MedGen" />
              <XRef ID="MONDO:0012455" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS610253" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 1</ElementValue>
                <XRef ID="MONDO:0027407" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsy / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C0795833" DB="MedGen" />
              <XRef ID="MONDO:0027407" DB="MONDO" />
              <XRef Type="MIM" ID="610253" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7332547" SubmissionDate="2023-11-09" DateLastUpdated="2023-11-11" DateCreated="2023-05-06">
        <ClinVarSubmissionID localKey="e6feef0e-569e-4bb3-acf2-c3d3636cceeb" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003922273" DateUpdated="2023-11-11" DateCreated="2023-05-06" Type="SCV" Version="2" SubmitterName="Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard" OrgID="506627" OrganizationCategory="laboratory" OrgAbbreviation="Broad RDG" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The heterozygous p.Asp351ThrfsTer66 variant in EHMT1 was identified by our study in one individual with hypertelorism, hypotonia, large hands and feet, and global developmental delay (Broad Institute Rare Genomes Project). Trio genome analysis showed this variant to be de novo. The p.Asp351ThrfsTer66 variant in EHMT1 has not been previously reported in individuals with Kleefstra syndrome 1. This variant was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein‚Äôs amino acid sequence beginning at position 351 and leads to a premature termination codon 66 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Heterozygous loss of function of the EHMT1 gene is an established disease mechanism in autosomal dominant Kleefstra syndrome 1. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Kleefstra syndrome 1. ACMG/AMP Criteria applied: PVS1, PS2_Supporting, PM2_Supporting (Richards 2015).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EHMT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001354612.2:c.958del</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.12:g.137743971del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0027407" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13232620</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9056115" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="101475123|Orphanet:ORPHA261494" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848433" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The p.Asp351ThrfsX66 variant in EHMT1 has not been previously reported in individuals with Kleefstra syndrome and was absent from large population studies. However, trio whole genome sequencing confirmed this variant to be de novo in an individual with global developmental delay, hypotonia, and mild dysmorphic features by the Broad Institute Rare Genomes Project. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 351 and leads to a premature termination codon 66 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Loss of function of the EHMT1 gene is an established disease mechanism in autosomal dominant Kleefstra syndrome. In summary, this variant meets criteria to be classified as pathogenic for autosomal dominant Kleefstra syndrome. ACMG/AMP Criteria applied: PVS1, PS2_Moderate, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EHMT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_024757.5:exon 6</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.12:g.137743971delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA261494" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7332547" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0027407" MappingRef="MONDO">
        <MedGen CUI="C0795833" Name="Kleefstra syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9056115" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA261494" MappingRef="Orphanet">
        <MedGen CUI="C4551771" Name="Kleefstra syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

